Skip to main content
Log in

BAL reduces complications and costs of SIRS

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2015 US dollars

Reference

  • Laplante S, et al. Impact of Fluid Choice in Systemic Inflammatory Response Syndrome Patients on Hospital Cost Savings. PharmacoEconomics-Open : 4 Sep 2017. Available from: URL: http://dx.doi.org/10.1007/s41669-017-0055-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

BAL reduces complications and costs of SIRS. PharmacoEcon Outcomes News 787, 7 (2017). https://doi.org/10.1007/s40274-017-4335-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4335-7

Navigation